Literature DB >> 15931531

[Unclear intraoperative cardiorespiratory decompensation. Anaphylactic reaction?].

P Iblher1, N Rotter, J Grabbe, H Gehring, T Meier.   

Abstract

During anaesthesia a patient is exposed to a variety of substances, all of which could lead to anaphylactic reactions. In addition, other drugs may exert clinical side-effects by non-immunological mechanisms, e.g. by direct stimulation of the release of histamine by mast cells. Initially, the observed symptoms, such as hypotension or tachycardia, may be misunderstood by the anaesthetist, leading to a possible delay in diagnosis and subsequent treatment of the anaphylactic event. Cardiac ischemia and lung embolisms are important differential diagnoses that often cannot be definitely ruled out during the acute situation and that have to be followed up once the patient has been stabilised. We report a case of anaphylactic reaction after the administration of ampicillin which required treatment and ventilation in the intensive care unit. Despite an accurate determination of serum tryptase levels, the diagnosis of an anaphylactic reaction to ampicillin was eventually confirmed by skin testing. During anaesthesia, anaesthetists should consider anaphylaxis when unforeseen symptoms such as bronchospasm, haemodynamical instability and/or flush arise. In cases of unexpected reactions, patients should undergo allergological follow-up to prevent fatal re-exposure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931531     DOI: 10.1007/s00101-005-0869-3

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  23 in total

1.  Usefulness of UniCAP-Tryptase fluoroimmunoassay in the diagnosis of anaphylaxis.

Authors:  E Enrique; P García-Ortega; O Sotorra; P Gaig; C Richart
Journal:  Allergy       Date:  1999-06       Impact factor: 13.146

2.  Management of anaphylactic shock evaluated using a full-scale anaesthesia simulator.

Authors:  J Jacobsen; A L Lindekaer; H T Ostergaard; K Nielsen; D Ostergaard; M Laub; P F Jensen; N Johannessen
Journal:  Acta Anaesthesiol Scand       Date:  2001-03       Impact factor: 2.105

3.  Weal and flare responses to intradermal rocuronium and cisatracurium in humans.

Authors:  J H Levy; M Gottge; F Szlam; R Zaffer; C McCall
Journal:  Br J Anaesth       Date:  2000-12       Impact factor: 9.166

4.  Anaphylaxis during anaesthesia. Results of a two-year survey in France.

Authors:  M C Laxenaire; P M Mertes
Journal:  Br J Anaesth       Date:  2001-10       Impact factor: 9.166

5.  Reducing the risk of anaphylaxis during anaesthesia. Abbreviated text.

Authors: 
Journal:  Ann Fr Anesth Reanim       Date:  2002-05

Review 6.  [Anaphylactic shock].

Authors:  U Müller-Werdan; K Werdan
Journal:  Anaesthesist       Date:  1997-06       Impact factor: 1.041

Review 7.  Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention.

Authors:  M Fisher; B A Baldo
Journal:  Eur J Anaesthesiol       Date:  1994-07       Impact factor: 4.330

8.  Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.

Authors:  Paul Michel Mertes; Marie-Claire Laxenaire; François Alla
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892

Review 9.  Mast cell tryptase: a review of its physiology and clinical significance.

Authors:  V Payne; P C A Kam
Journal:  Anaesthesia       Date:  2004-07       Impact factor: 6.955

Review 10.  Adverse reactions to neuromuscular blocking agents.

Authors:  Paul-Michel Mertes; Marie Claire Laxenaire
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

View more
  1 in total

1.  [Severe anaphylaxis from rocuronium].

Authors:  J C Kubitz; T Krause; R Dietz; P Friederich; A E Goetz
Journal:  Anaesthesist       Date:  2006-11       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.